Cancer is undoubtedly a formidable disease. What is known as “immunotherapy” is increasingly becoming the scientific focus in the fight against it. Can a particular patient be treated using this approach? How does the tumor protect itself? Which immunotherapy should be used? With her ERC-supported project Dr Larysa Baraban from the HZDR Institute of Radiopharmaceutical Cancer Research aims to develop a platform called “ImmunoChip” to study the elements of the cancer-immunity cycle using nanolectronics as a tool. In order to digitilize the tumor properties, Larysa is expanding the portfolio of methods in cancer research to include nanosensor technology.
This continues her prior work on developing bio-nanosensors for medical diagnostics. This research has a high potential to lead to customized immunotherapies and therefore to an improvement in treatment results, ultimately helping to save more lives.
- Dr Denys Makarov (HZDR, Germany): ERC Starting Grant “SMaRT: Shapeable Magnetoelectronics in Research and Technology” in 2012 and an ERC Proof-of-Concept Grant “MagnetoFLEX: Ultra-thin flexible Magnetic sensorics” in 2013 and “ANALYTICS: All-electrical analytic platform for digital fluidics” in 2017.
- Prof. Andrii Chumak (NanoMagnonics, Faculty of Physics, University of Vienna): ERC Starting Grant MAGNONCIRCUITS: “Nano-Scale Magnonic Circuits for Novel Computing Systems” in 2016
- Dr Anton Kuzyk (University of Aalto, Finland): ERC Consolidator Grant “Electrically driven DNA- origami-based machines” in 2021